119
Participants
Start Date
May 31, 2012
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
Resveratrol
The dosage will begin at 500 mg taken once daily and increase at 13 week intervals to 1 gram taken by mouth twice daily, supplied as 500 mg capsules (two capsules twice daily).
Placebo
The matching placebo will begin at a capsule taken once daily and increase at 13 week intervals to two capsules twice daily.
New York University, New York
Mount Sinai School of Medicine, New York
Columbia University, New York
University of Rochester Medical Center, Rochester
University of Pennsylvania, Philadelphia
Georgetown University, Washington D.C.
Howard University, Washington D.C.
Johns Hopkins University, Baltimore
Medical University of South Carolina, North Charleston
Mayo Clinic, Jacksonville, Jacksonville
University of South Florida, Tampa
University of Kentucky, Lexington
Case Western Reserve University, Beachwood
University of Michigan, Ann Arbor
Mayo Clinic, Rochester, Rochester
Rush University Medical Center, Chicago
University of Kansas, Kansas City
University of Texas Southwestern Medical Center, Dallas
Baylor College of Medicine, Houston
Banner Alzheimer's Institute, Phoenix
Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas
University of Southern California, Los Angeles
University of California, San Diego - Comprehensive Alzheimer's Program, La Jolla
University of California, Irvine, Irvine
U of WA / VA Puget Sound Alzheimer's Disease Research Center, Seattle
Yale University, New Haven
National Institute on Aging (NIA)
NIH
Alzheimer's Disease Cooperative Study (ADCS)
OTHER